skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 81  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWI
Material Type:
Conference Proceeding
Add to My Research

052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWI

BMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.52 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.52

Full text available

2
O33 Qualitative story completion: an innovative method with exciting potential for health research
Material Type:
Conference Proceeding
Add to My Research

O33 Qualitative story completion: an innovative method with exciting potential for health research

BMJ open, 2019, Vol.9 (Suppl 1), p.A13-A13 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.33

Full text available

3
1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencing
Material Type:
Conference Proceeding
Add to My Research

1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencing

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1320-A1321 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1272

Full text available

4
750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies
Material Type:
Conference Proceeding
Add to My Research

750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A783-A783 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0750

Full text available

5
P17 Adopting the nominal group technique to understand the use of religious practices and experiences
Material Type:
Conference Proceeding
Add to My Research

P17 Adopting the nominal group technique to understand the use of religious practices and experiences

BMJ open, 2019, Vol.9 (Suppl 1), p.A20-A20 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.52

Full text available

6
526 miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
Material Type:
Conference Proceeding
Add to My Research

526 miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A551-A551 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0526

Full text available

7
1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma models
Material Type:
Conference Proceeding
Add to My Research

1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma models

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1179-A1179 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1135

Full text available

8
715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials
Material Type:
Conference Proceeding
Add to My Research

715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A748-A748 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0715

Full text available

9
1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates
Material Type:
Conference Proceeding
Add to My Research

1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1198-A1198 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1155

Full text available

10
769 Results from an ongoing open-label, multicenter, phase 1 trial of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors
Material Type:
Conference Proceeding
Add to My Research

769 Results from an ongoing open-label, multicenter, phase 1 trial of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A800-A800 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0769

Full text available

11
058: EVALUATING A COMPLEX CAPACITY-BUILDING INTERVENTION IN AN INTERNATIONAL DEVELOPMENT CONTEXT: REFLECTING ON THE AFRICAN INSTITUTIONS INITIATIVE EVALUATION
Material Type:
Conference Proceeding
Add to My Research

058: EVALUATING A COMPLEX CAPACITY-BUILDING INTERVENTION IN AN INTERNATIONAL DEVELOPMENT CONTEXT: REFLECTING ON THE AFRICAN INSTITUTIONS INITIATIVE EVALUATION

BMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.58 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.58

Full text available

12
021: SEROPREVALENCE OF HISTOPLASMA CAPSULATUM INFECTION AMONG THE NEARBY RESIDENTS OF BAT CAVES IN ISLAND GARDEN CITY OF SAMAL, DAVAO DEL NORTE
Material Type:
Conference Proceeding
Add to My Research

021: SEROPREVALENCE OF HISTOPLASMA CAPSULATUM INFECTION AMONG THE NEARBY RESIDENTS OF BAT CAVES IN ISLAND GARDEN CITY OF SAMAL, DAVAO DEL NORTE

BMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.21 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.21

Full text available

13
Pharmacokinetic Modeling of VV116 for Treatment of COVID-19
Material Type:
Conference Proceeding
Add to My Research

Pharmacokinetic Modeling of VV116 for Treatment of COVID-19

BIO Web of Conferences, 2023, Vol.60, p.2007 [Peer Reviewed Journal]

2023. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2117-4458 ;ISSN: 2273-1709 ;EISSN: 2117-4458 ;DOI: 10.1051/bioconf/20236002007

Full text available

14
Towards Computational Content Analysis of Crises-Related News in Electronic Media
Material Type:
Conference Proceeding
Add to My Research

Towards Computational Content Analysis of Crises-Related News in Electronic Media

Central European Conference on Information and Intelligent Systems, 2023, p.407-416

2023. This work is published under http://archive.ceciis.foi.hr/app/index.php/ceciis/archive (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1847-2001 ;EISSN: 1848-2295

Full text available

15
Optimizing Point Cloud Processing for Facial Reconstruction Using Open-Source Tools: A Preliminary Study
Material Type:
Conference Proceeding
Add to My Research

Optimizing Point Cloud Processing for Facial Reconstruction Using Open-Source Tools: A Preliminary Study

Central European Conference on Information and Intelligent Systems, 2023, p.361-368

2023. This work is published under http://archive.ceciis.foi.hr/app/index.php/ceciis/archive (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1847-2001 ;EISSN: 1848-2295

Full text available

16
885 Enhancing immune checkpoint inhibitor efficacy with anti-angiogenics in ovarian cancer
Material Type:
Conference Proceeding
Add to My Research

885 Enhancing immune checkpoint inhibitor efficacy with anti-angiogenics in ovarian cancer

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A922-A922 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0885

Full text available

17
O32 Evolving ethnographic sensibilities: using actor-network theory in health services research
Material Type:
Conference Proceeding
Add to My Research

O32 Evolving ethnographic sensibilities: using actor-network theory in health services research

BMJ open, 2019, Vol.9 (Suppl 1), p.A12-A12 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.32

Full text available

18
O13 Rules of engagement: ethics issues in participatory research
Material Type:
Conference Proceeding
Add to My Research

O13 Rules of engagement: ethics issues in participatory research

BMJ open, 2019, Vol.9 (Suppl 1), p.A5-A5 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.13

Full text available

19
O15 Building sustainable partnerships with local researchers for qualitative health systems research
Material Type:
Conference Proceeding
Add to My Research

O15 Building sustainable partnerships with local researchers for qualitative health systems research

BMJ open, 2019, Vol.9 (Suppl 1), p.A6-A6 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.15

Full text available

20
P1 Notions of safety and risk in palliative care: the role of qualitative health research
Material Type:
Conference Proceeding
Add to My Research

P1 Notions of safety and risk in palliative care: the role of qualitative health research

BMJ open, 2019, Vol.9 (Suppl 1), p.A14-A15 [Peer Reviewed Journal]

2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2019-QHRN.37

Full text available

Results 1 - 20 of 81  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (56)

Searching Remote Databases, Please Wait